Inj. biosynthetic r-dna origin mixture of 50 percent soluble insulin aspart (rys) and 50 percent protamine crystallised insulin aspart 100iu/ml 03 ml cartridge with complimentary pen and ultrafine nano needle.

Insulin degludec (2.56mg) insulin aspart (1.05mg) , 3ml prefilled pen

Running contract for inj.insulin glulisine (monocomponent insulin glulisine) with one free pen and 8 needle per 20 cartridges.

Inj.insulin aspart (30 percent ) + insulin aspart protamine (70 percent ) cartridge

Needle 16g,syringe 5 ml,syringe 10 ml,syringe 20 ml,epidural needle 18g,epidural needle 20 g,edta tube,plain tube,surgical gloves sterile,insulin syringe,stterile soft swab

Hq_med_sur_(ph no.:31034) disp. syringes 1 ml with needle 30 g - 40 iu/ ml for insulin

Biphasic isophane insulin 30/70 injection (100iu/ml) , (r-dna origin) , 3ml cartridge,multivitamin

Hq_med_gte_zrc_zonal rate contract for supply of (ph no.:31280) monocomponent biosynthetic r-dna insulin solution for injecton in cartridge 70 percent insulin degludec + 30 percent insulin aspart - 100 u/ml - 3 ml

Inj. insulin degludec with insulin aspart

Syringes 2ml,syringes with needle,syringes,insuline syringes,needle,needle,needle